Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Dopaminergic agonists for hepatic encephalopathy

Esta versión no es la más reciente

ver la versión actual 10 febrero 2014

Información

DOI:
https://doi.org/10.1002/14651858.CD003047.pub2Copiar DOI
Base de datos:
  1. Cochrane Database of Systematic Reviews
Versión publicada:
  1. 18 octubre 2004see what's new
Tipo:
  1. Intervention
Etapa:
  1. Review
Grupo Editorial Cochrane:

  1. Grupo Cochrane de Hepatobiliar

Copyright:
  1. Copyright © 2009 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Cifras del artículo

Altmetric:

Citado por:

Citado 0 veces por enlace Crossref Cited-by

Contraer

Autores

  • Bodil Als‐Nielsen

    Correspondencia a: Cochrane Hepato‐Biliary Group, Copenhagen Trial Unit, Centre for Clinical Intervention Research, Copenhagen, Denmark

    [email protected]

  • Lise Lotte Gluud

    Cochrane Hepato‐Biliary Group, Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 3344, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark

  • Christian Gluud

    Cochrane Hepato‐Biliary Group, Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 3344, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark

Contributions of authors

Bodil Als‐Nielsen drafted the protocol, identified trials, extracted data, performed the statistical analyses, and drafted the review. Lise Lotte Gluud selected trials for inclusion and extracted data. All reviewers contributed to the writing of the protocol and review and all have approved of the final version.

Sources of support

Internal sources

  • Copenhagen Trial Unit, Denmark.

External sources

  • The 1991 Pharmacy Foundation, Denmark.

  • Danish Center for Evaluation and Health Technology Assessment (DACEHTA), Denmark.

Declarations of interest

None known.

Acknowledgements

We thank Sarah Frederiksen for performing the electronic literature search. We thank Marsha Morgan and Misael Uribe for additional information on their trials.

Version history

Published

Title

Stage

Authors

Version

2014 Feb 10

Dopamine agents for hepatic encephalopathy

Review

Anders Ellekær Junker, Bodil Als‐Nielsen, Christian Gluud, Lise Lotte Gluud

https://doi.org/10.1002/14651858.CD003047.pub3

2004 Oct 18

Dopaminergic agonists for hepatic encephalopathy

Review

Bodil Als‐Nielsen, Lise Lotte Gluud, Christian Gluud

https://doi.org/10.1002/14651858.CD003047.pub2

2000 Jul 24

Dopaminergic agents for hepatic encephalopathy

Protocol

Bodil Als‐Nielsen, L L Kjaergard, Christian Gluud, Lise Lotte Kjærgård

https://doi.org/10.1002/14651858.CD003047

PICO

Population
Intervention
Comparison
Outcome

El uso y la enseñanza del modelo PICO están muy extendidos en el ámbito de la atención sanitaria basada en la evidencia para formular preguntas y estrategias de búsqueda y para caracterizar estudios o metanálisis clínicos. PICO son las siglas en inglés de cuatro posibles componentes de una pregunta de investigación: paciente, población o problema; intervención; comparación; desenlace (outcome).

Para saber más sobre el uso del modelo PICO, puede consultar el Manual Cochrane.